This document discusses the history of opiate commercialization and addiction. It begins with the British East India Company trading opium to China in the 17th-18th centuries, leading to widespread addiction. In the 1990s, Purdue Pharma aggressively marketed OxyContin, leading to its overprescription and misuse. Today, 30-40% of prescribed opiates are misused. The document outlines strategies to educate prescribers on appropriate opiate prescribing through training, monitoring programs, and care agreements with patients.